Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:33:28.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety assessment of nemolizumab in subjects with moderate-to-severe atopic dermatitis after a 16-week treatment period. This change reflects potential advancements in medical research and healthcare-related publications.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:37.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to include detailed eligibility criteria for study participants, specifying age, health conditions, and prior treatments required for inclusion in the study. Previously, no information was provided in this section.
    Difference
    14%
    Check dated 2024-05-22T21:15:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:53:07.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.